| Gene therapy: Comprehensive overview and therapeutic applications N Sayed, P Allawadhi, A Khurana, V Singh, U Navik, SK Pasumarthi, ... Life sciences 294, 120375, 2022 | 216 | 2022 |
| Structure-Based Identification of Potential Drugs Against FmtA of Staphylococcus aureus: Virtual Screening, Molecular Dynamics, MM-GBSA, and QM/MM V Dalal, P Dhankhar, V Singh, V Singh, G Rakhaminov, D Golemi-Kotra, ... The protein journal 40, 148-165, 2021 | 95 | 2021 |
| Silver nanoparticle based multifunctional approach for combating COVID-19 P Allawadhi, V Singh, A Khurana, I Khurana, S Allwadhi, P Kumar, ... Sensors International 2, 100101, 2021 | 85 | 2021 |
| Apoptosis and pharmacological therapies for targeting thereof for cancer therapeutics V Singh, A Khurana, U Navik, P Allawadhi, KK Bharani, R Weiskirchen Sci 4 (2), 15, 2022 | 66 | 2022 |
| Biomedical applications of polysaccharide nanoparticles for chronic inflammatory disorders: Focus on rheumatoid arthritis, diabetes and organ fibrosis P Allawadhi, V Singh, K Govindaraj, I Khurana, LP Sarode, U Navik, ... Carbohydrate polymers 281, 118923, 2022 | 60 | 2022 |
| Computational guided identification of novel potent inhibitors of N-terminal domain of nucleocapsid protein of severe acute respiratory syndrome coronavirus 2 P Dhankhar, V Dalal, V Singh, S Tomar, P Kumar Journal of Biomolecular Structure and Dynamics 40 (9), 4084-4099, 2022 | 51 | 2022 |
| In-silico functional and structural annotation of hypothetical protein from Klebsiella pneumonia: A potential drug target V Singh, P Dhankhar, V Dalal, S Tomar, P Kumar Journal of Molecular Graphics and Modelling 116, 108262, 2022 | 34 | 2022 |
| Decorin as a possible strategy for the amelioration of COVID-19 P Allawadhi, V Singh, I Khurana, PS Rawat, AP Renushe, A Khurana, ... Medical Hypotheses 152, 110612, 2021 | 29 | 2021 |
| Critical neurological features of COVID-19: Role of imaging methods and biosensors for effective diagnosis V Singh, P Allawadhi, A Khurana, AK Banothu, KK Bharani Sensors international 2, 100098, 2021 | 29 | 2021 |
| Emerging role of PD-1/PD-L1 inhibitors in chronic liver diseases V Singh, A Khurana, P Allawadhi, AK Banothu, KK Bharani, ... Frontiers in Pharmacology 12, 790963, 2021 | 24 | 2021 |
| Drug-Repurposing Approach To Combat Staphylococcus aureus: Biomolecular and Binding Interaction Study V Singh, P Dhankhar, V Dalal, S Tomar, D Golemi-Kotra, P Kumar ACS omega 7 (43), 38448-38458, 2022 | 23 | 2022 |
| A comprehensive overview of CRISPR/Cas 9 technology and application thereof in drug discovery A Khurana, N Sayed, V Singh, I Khurana, P Allawadhi, PS Rawat, U Navik, ... Journal of Cellular Biochemistry 123 (10), 1674-1698, 2022 | 17 | 2022 |
| Antimicrobial and anti-viral effects of selenium nanoparticles and selenoprotein based strategies: COVID-19 and beyond A Khurana, P Allawadhi, V Singh, I Khurana, P Yadav, KB Sathua, ... Journal of Drug Delivery Science and Technology 86, 104663, 2023 | 12 | 2023 |
| Bacterial histidine kinases as potential antibacterial drug targets V Singh, P Dhankhar, P Kumar Protein Kinase Inhibitors, 711-734, 2022 | 3 | 2022 |
| Computational guided identification of novel potent inhibitors of NTD-N-protein of SARS-CoV-2 P Dhankhar, V Singh, S Tomar | 3 | 2020 |
| Pharmacological Modeling of Gastrointestinal Disorders in Zebrafish for Drug Discovery and Development V Singh, AP Renushe, P Allawadhi, SK Pasumarthi, I Khurana, ... Zebrafish Model for Biomedical Research, 421-447, 2022 | 1 | 2022 |
